HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 921 | 1049 | 87.8% | |
| HF 4 | 2011 | 1040 | 1205 | 86.3% | |
| HF 4 | 2012 | 1198 | 1383 | 86.6% | |
| HF 4 | 2013 | 1334 | 1469 | 90.8% | |
| HF004(S) | 2014 | 644 | 687 | 93.7% | |
| HF004(S) | 2015 | 707 | 763 | 92.7% | |
| HF004(S) | 2016 | 866 | 959 | 90.3% |
